MedPath

ZYNYZ

ZYNYZ

Approved
DIN Number

02555239

Drug Class

Human

Market Date

N/A

Company
HC

因塞特

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02555239
AIG Number0166504001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FF10 RETIFANLIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

RETIFANLIMABActive
Strength: 25 MG / ML
Monograph: RETIFANLIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.